Please assess the completion status of the following clinical trial:

Trial Title: Comparison Between the Effects of High Doses Statin on Ventricular Remodeling in STEMI Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Electrocardiogram showed abnormal elevation of the ST segment.~2. First myocardial infarction occurred.~3. The patients received one-stage percutaneous coronary intervention (PCI) therapy within 12 h.~Exclusion Criteria:~1. Severe cardiac insufficiency.~2. Hepatic insufficiency (continuous increase of serum transaminase more than 3 times of the upper limit of normal level).~3. Renal insufficiency (creatinine clearance rate \<30 mL/min).~4. Addition of others blood lipid lowering and antioxidant drugs during follow up period.~5. Familial hypercholesterolemia.~6. Malignant tumor.~7. Immune system disease.~8. Acute infectious disease.~9. Hypersensitivity to rosuvastatin and Atorvastatin.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Rosuvastatin group (Type: EXPERIMENTAL): patients will receive Rosuvastatin orally (20 mg) at night once daily
- Atorvastatin group (Type: EXPERIMENTAL): patients will receive Atorvastatin orally (40 mg) at night once daily

Based on this trial design, predict the completion outcome and termination type (if applicable).